about
Antiviral Treatment Guidelines for Middle East Respiratory SyndromeClinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea.A Case of Severe HIV-Associated Psoriasis Successfully Treated with Acitretin Therapy.Clinical manifestations and diagnosis of extrapulmonary tuberculosis.Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome.Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South KoreaPost-infectious irritable bowel syndrome in patients with Shigella infectionClinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19
P50
Q26781374-505B5B8E-31C7-494F-96F5-5EC40BE06714Q33434003-2EF86CD0-2F68-4422-AF42-E09C6E1A4F2EQ33879474-EBB2B7DF-9DFA-44EC-9C98-85C910A6666EQ47263083-F29D5302-E42A-4A4D-B6A1-497BCF4C129EQ55442944-F86C1858-E065-4FE2-A0A6-55F2B0DAC244Q61804910-410518E0-DF5A-409F-8F9A-4D6C32CB6EA5Q81459491-04771191-F9B0-4BFF-BFDD-5DA05CFF22DEQ91524380-A87B0E7C-9444-4C24-8BA7-5ECB09A110B0
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4805-7930
@en
name
Jae-Phil Choi
@ast
Jae-Phil Choi
@en
Jae-Phil Choi
@es
Jae-Phil Choi
@nl
type
label
Jae-Phil Choi
@ast
Jae-Phil Choi
@en
Jae-Phil Choi
@es
Jae-Phil Choi
@nl
prefLabel
Jae-Phil Choi
@ast
Jae-Phil Choi
@en
Jae-Phil Choi
@es
Jae-Phil Choi
@nl
P106
P31
P496
0000-0003-4805-7930